Hence, there might be an interaction between PDL1 expression on myofibroblasts and autophagy in IPF, and they could be novel biomarkers and therapeutic targets in IPF diagnosis and treatment. This evidence concerns the gene CD274 and idiopathic pulmonary fibrosis.